D. Millson

发表

As clean as they look? Food hygiene inspection scores, microbiological contamination, and foodborne illness

G. Poppy, J. Fleetwood, Shamim Rahman, 2019, Food Control.

A comparison of trends in problematic drug misuse from two reporting systems.

M. Frischer, J. Bashford, J. Norwood, 2000, Journal of public health medicine.

Substance misuse and psychiatric illness: prospective observational study using the general practice research database

J. Macleod, P. Croft, M. Frisher, 2005, Journal of Epidemiology and Community Health.

Cost-Effectiveness Analysis of Stratified Versus Stepped Care Strategies for Acute Treatment of Migraine

M. Sculpher, D. Meddis, D. Millson, 2012, PharmacoEconomics.

What has happened to antimicrobial usage in primary care in the United Kingdom since the SMAC report? - description of trends in antimicrobial usage using the General Practice Research Database.

N. Verlander, Gillian E. Smith, J. Hawker, 2004, Journal of public health.

Abstracts and Citations

S. Tepper, D. Millson, 1992 .

Defining the spectrum of appropriate prescribing: implications for effective medicines management

M. Frischer, D. Millson, H. Heatlie, 2000, International Journal of Pharmaceutical Medicine.

Abstracts and Citations

S. Tepper, D. Millson, 1991 .

Pharmacokinetic Properties of Fostamatinib in Patients With Renal or Hepatic Impairment: Results From 2 Phase I Clinical Studies.

Paul D. Martin, S. Oliver, T. Marbury, 2015, Clinical therapeutics.

Abstracts and Citations

S. Tepper, D. Millson, 2004 .

Are Triptans with Enhanced Lipophilicity Used for the Acute Treatment of Migraine Associated with an Increased Consulting Rate for Depressive Illness?

P. Croft, M. Frischer, P. Goadsby, 2000, Cephalalgia : an international journal of headache.

Should the corticosteroid to bronchodilator ratio be promoted as a quality prescribing marker?

M. Frischer, J. Bashford, J. Norwood, 1999, Public health.

Safety profile of the triptans

S. Tepper, D. Millson, 2003, Expert opinion on drug safety.

Psychological, Sleep, Lifestyle, and Comorbid Associations With Headache

P. Croft, E. Thomas, H. Boardman, 2005, Headache.

Migraine pharmacotherapy with oral triptans: a rational approach to clinical management

S. Tepper, A. Rapoport, D. Millson, 2000, Expert opinion on pharmacotherapy.

Identification of β adrenoceptors during thymocyte ontogeny in mice

D. Millson, J. Owen, J. Owen, 1979 .

Ratio of Inhaled Corticosteroid to Bronchodilator Treatment and Asthma Hospitalisation

M. Frischer, J. Norwood, D. Millson, 2000, Current medical research and opinion.

One‐Year Follow‐Up of Headache in an Adult General Population

P. Croft, E. Thomas, H. Boardman, 2005, Headache.

Safety and efficacy of fostamatinib in rheumatoid arthritis patients with an inadequate response to methotrexate in phase II OSKIRA-ASIA-1 and OSKIRA-ASIA-1X study.

Yoshiya Tanaka, S. Nakayamada, S. Iwata, 2020, Rheumatology.

Tolerability profile of zolmitriptan (Zomig; 311C90), a novel dual central and peripherally acting 5HT1B/1D agonist. International clinical experience based on > 3000 subjects treated with zolmitriptan.

J. Edmeads, D. Millson, Jg Edmeads, 1997, Cephalalgia : an international journal of headache.

Upper Gastroduodenal Ulceration in Arthritis Patients Treated with Celecoxib

D. Ashcroft, W. Clark, D. Millson, 2001, The Annals of pharmacotherapy.

Naratriptan for the treatment of acute migraine: meta‐analysis of randomised controlled trials

D. Ashcroft, D. Millson, 2004, Pharmacoepidemiology and drug safety.

The effects of a selective 5-HT2 receptor antagonist (ICI 170,809) on platelet aggregation and pupillary responses in healthy volunteers.

D. Millson, S. Haworth, A. Rushton, 1992, British journal of clinical pharmacology.

A long-term study to maximise migraine relief with zolmitriptan.

A. Dowson, S. Tepper, D. Millson, 1999, Current medical research and opinion.

Effects of CYP3A4 Inhibitors Ketoconazole and Verapamil and the CYP3A4 Inducer Rifampicin on the Pharmacokinetic Parameters of Fostamatinib: Results from In Vitro and Phase I Clinical Studies

Paul D. Martin, S. Oliver, C. Brealey, 2016, Drugs in R&D.

Effects of Fostamatinib, an Oral Spleen Tyrosine Kinase Inhibitor, in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate: Results From a Phase III, Multicenter, Randomized, Double‐Blind, Placebo‐Controlled, Parallel‐Group Study

Gustavo Leon, M. Genovese, M. Weinblatt, 2014, Arthritis & rheumatology.

Effects of Fostamatinib on the Pharmacokinetics of the CYP2C8 Substrate Pioglitazone: Results From In Vitro and Phase 1 Clinical Studies

Paul D. Martin, D. Surry, S. Oliver, 2016, Clinical pharmacology in drug development.

Issues relating to the assessment of migraine recurrence following triptan therapy

S. Tepper, D. Millson, 1999, European journal of neurology.

Prevalence of comorbid psychiatric illness and substance misuse in primary care in England and Wales

P. Croft, M. Frisher, I. Crome, 2004, Journal of Epidemiology and Community Health.

Cost-effectiveness analysis of stratified versus stepped care strategies for acute treatment of migraine: The Disability in Strategies for Care (DISC) Study.

M. Sculpher, D. Meddis, D. Millson, 2002, PharmacoEconomics.

Oral zolmitriptan is effective in the acute treatment of cluster headache

P. Goadsby, J. Hardebo, D. Millson, 2000, Neurology.

The effects of a 5-HT2 receptor antagonist (ICI 169,369) on changes in waking EEG, pupillary responses and state of arousal in human volunteers.

D. Millson, S. Haworth, A. Rushton, 1991, British journal of clinical pharmacology.

Use of doppler echocardiography to determine the cardiac effects of dobutamine in volunteers

D. Millson, J. Harry, P. Morton, 1988 .

Trends in antibiotic prescribing and associated indications in primary care from 1993 to 1997.

M. Frischer, J. Bashford, J. Norwood, 2001, Journal of public health medicine.

Identification of beta adrenoreceptors during thymocyte ontogeny in mice.

D. Millson, J. Owen, U. Singh, 1979, European journal of immunology.

A method to determine if consenters to population surveys are representative of the target study population.

P. Croft, E. Thomas, H. Ogden, 2005, Journal of public health.

The Natural History of Headache: Predictors of Onset and Recovery

P. Croft, E. Thomas, H. Boardman, 2006, Cephalalgia : an international journal of headache.

Cross‐sectional survey of medication used for headache in a general population

P. Croft, E. Thomas, H. Boardman, 2004 .

Abstracts and Citations

S. Tepper, D. Millson, 2003 .

A community pharmacy based survey of users of over the counter sleep aids

P. Croft, A. Blenkinsopp, D. Millson, 2002 .

The effects of temperature and ionic environment on antagonist binding to cardiac f-adrenoceptors

B. R. Smith, D. Millson, 2007 .

Effects of Fostamatinib on the Pharmacokinetics of Digoxin (a P-Glycoprotein Substrate): Results From in Vitro and Phase I Clinical Studies.

Paul D. Martin, S. Oliver, C. Brealey, 2015, Clinical therapeutics.

Abstracts and Citations

S. Tepper, D. Millson, 2004 .